The stock of Ocean Biomedical Inc (NASDAQ: OCEA) has decreased by -1.03 when compared to last closing price of 0.04. Despite this, the company has experienced a -3.69% fall in its stock price over the last five trading sessions. globenewswire.com reported 2025-02-10 that Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma Interest Providence, RI, Feb. 10, 2025 (GLOBE NEWSWIRE) — Ocean Biomedical (NASDAQ: OCEA) today announced newly published research findings demonstrating the ability of its proprietary cancer immunotherapy candidates to favorably interact with tyrosine kinase inhibitors (TKI), such as osimertinib that are used to treat non-small cell lung cancer (NSCLC). Specifically, they demonstrate that Ocean’s immunotherapy candidates provide synergy with the TKI therapies (gefitinib and osimertinib) to suppress tumor growth and progression.
Is It Worth Investing in Ocean Biomedical Inc (NASDAQ: OCEA) Right Now?
The 36-month beta value for OCEA is at 1.66. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for OCEA is 139.09M, and currently, shorts hold a 2.11% of that float. The average trading volume for OCEA on April 14, 2025 was 54.08M shares.
OCEA’s Market Performance
OCEA’s stock has seen a -3.69% decrease for the week, with a -30.79% drop in the past month and a -93.70% fall in the past quarter. The volatility ratio for the week is 18.98%, and the volatility levels for the past 30 days are at 24.09% for Ocean Biomedical Inc The simple moving average for the last 20 days is -22.62% for OCEA stock, with a simple moving average of -93.69% for the last 200 days.
OCEA Trading at -53.37% from the 50-Day Moving Average
After a stumble in the market that brought OCEA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.24% of loss for the given period.
Volatility was left at 24.09%, however, over the last 30 days, the volatility rate increased by 18.98%, as shares sank -30.32% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -77.97% lower at present.
During the last 5 trading sessions, OCEA fell by -3.36%, which changed the moving average for the period of 200-days by -96.85% in comparison to the 20-day moving average, which settled at $0.0557. In addition, Ocean Biomedical Inc saw -92.22% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for OCEA
Based on Ocean Biomedical Inc (OCEA), the company’s capital structure generated -0.2 points at debt to capital in total, while cash flow to debt ratio is standing at -0.26.
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.03.
Conclusion
In conclusion, Ocean Biomedical Inc (OCEA) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
